CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-08-23 | HIGGINS JOHN L Director | Option exercise | +10,000 | $61.08 | $611K | 13,012 |
| 2018-08-23 | HIGGINS JOHN L Director | Sale | −10,000 | $187.92 | $1.9M | 3,012 |
| 2018-08-23 | HIGGINS JOHN L Director | Option exercise · Stock Option (right to buy) | −10,000 | 0 | ||
| 2018-08-18 | Kummeth Charles R. Chief Executive Officer | Shares withheld for taxes | −1,338 | $180.50 | $242K | 92,176 |
| 2018-08-08 | Kelderman Kim President, Diagnostics & Genom | Grant or award · Restricted Stock Units | +1,691 | 1,691 | ||
| 2018-08-08 | Kelderman Kim President, Diagnostics & Genom | Grant or award · Stock Options (Right to buy) | +12,044 | 12,044 | ||
| 2018-08-08 | Kelderman Kim President, Diagnostics & Genom | Grant or award · Stock Options (Right to buy) | +9,033 | 9,033 | ||
| 2018-08-08 | Dinarello Charles A Director | Option exercise | +5,000 | $63.03 | $315K | 13,212 |
| 2018-08-08 | Dinarello Charles A Director | Sale | −5,000 | $176.94 | $885K | 8,212 |
| 2018-08-08 | Dinarello Charles A Director | Option exercise · Stock Options (Right to buy) | −5,000 | 0 | ||
| 2018-08-08 | Kummeth Charles R. Chief Executive Officer | Grant or award | +11,279 | 93,514 | ||
| 2018-08-08 | Kummeth Charles R. Chief Executive Officer | Grant or award · Restricted Stock Units | +16,918 | 16,918 | ||
| 2018-08-08 | Kummeth Charles R. Chief Executive Officer | Grant or award · Stock Options (Right to buy) | +60,222 | 60,222 | ||
| 2018-08-08 | Kummeth Charles R. Chief Executive Officer | Grant or award · Stock Options (Right to buy) | +90,334 | 90,334 | ||
| 2018-08-08 | Eansor Norman David SVP - Novus Biologicals | Grant or award · Restricted Stock Units | +2,537 | 2,537 | ||
| 2018-08-08 | Eansor Norman David SVP - Novus Biologicals | Grant or award · Stock Options (Right to buy) | +18,066 | 18,066 | ||
| 2018-08-08 | Eansor Norman David SVP - Novus Biologicals | Grant or award · Stock Options (Right to buy) | +13,550 | 13,550 | ||
| 2018-08-08 | Furlow Brenda S. SVP - General Counsel | Grant or award · Restricted Stock Units | +1,374 | 1,374 | ||
| 2018-08-08 | Furlow Brenda S. SVP - General Counsel | Grant or award · Stock Options (Right to buy) | +9,786 | 9,786 | ||
| 2018-08-08 | Furlow Brenda S. SVP - General Counsel | Grant or award · Stock Options (Right to buy) | +7,339 | 7,339 |
Page 54 of 64 · 1,274 trades